Source:http://linkedlifedata.com/resource/pubmed/id/11273908
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-3-29
|
pubmed:abstractText |
We studied the effects of protamine (10-300 microg. mL(-1)) as well as its interaction with heparin in rat left ventricular papillary muscles in vitro at calcium concentrations of 0.5 and 1 mM under low (isotony) and high (isometry) loads. Protamine induced a negative inotropic effect that was less pronounced at calcium 0.5 mM (active force at protamine 300 microg/mL, 84 +/- 20 vs 57 +/- 15% of baseline, P: < 0.05); whereas at calcium 1 mM there was a marked contracture of the muscle. For the smallest concentrations of protamine and at calcium 0.5 mM, we observed a moderate positive inotropic effect that was suppressed by nifedipine. Protamine induced a negative lusitropic effect under low load and decreased postrest potentiation, suggesting an impairment in the functions of the sarcoplasmic reticulum. Heparin was able to inhibit and reverse the negative inotropic effect of protamine. The negative inotropic effect of protamine is enhanced by an increase in extracellular calcium concentration. This negative inotropic effect is probably related to calcium overload and impairment in sarcoplasmic reticulum functions, and heparin can block these effects. Implications: The negative inotropic effect of protamine is enhanced by an increase in extracellular calcium concentration. This negative inotropic effect is probably related to calcium overload and impairment in sarcoplasmic reticulum functions, and heparin can block these effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Protamines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
817-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11273908-Animals,
pubmed-meshheading:11273908-Anticoagulants,
pubmed-meshheading:11273908-Calcium,
pubmed-meshheading:11273908-Cardiotonic Agents,
pubmed-meshheading:11273908-Extracellular Space,
pubmed-meshheading:11273908-Heart Ventricles,
pubmed-meshheading:11273908-Heparin,
pubmed-meshheading:11273908-Heparin Antagonists,
pubmed-meshheading:11273908-Male,
pubmed-meshheading:11273908-Myocardial Contraction,
pubmed-meshheading:11273908-Papillary Muscles,
pubmed-meshheading:11273908-Protamines,
pubmed-meshheading:11273908-Rats,
pubmed-meshheading:11273908-Rats, Wistar
|
pubmed:year |
2001
|
pubmed:articleTitle |
Extracellular calcium modulates the effects of protamine on rat myocardium.
|
pubmed:affiliation |
Department of Anesthesiology and Critical Care, Centre Hospitalier Universitaire (CHU) Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Pierre et Marie Curie, Paris, France.
|
pubmed:publicationType |
Journal Article,
In Vitro
|